Androgen Deprivation Therapy and Risk of Cardiovascular Disease in Patients With Prostate Cancer Based on Existence of Cardiovascular Risk.

Alice Dragomir,Nawar Touma,Jason Hu,Sylvie Perreault,Armen G Aprikian

Journal of the National Comprehensive Cancer Network : JNCCN（2023）

引用 1|浏览14

暂无评分

摘要

Compared with GnRH agonists, the GnRH antagonist was found to be associated with a decreased risk of HF, specifically among patients with prior CVD. Among those with no prior CVD, the GnRH antagonist was associated with a decreased risk of IHD but an increased risk of arrhythmia.

查看译文

关键词

GnRH agonist,GnRH antagonist,androgen deprivation therapy,cardiovascular risk,prostate cancer

AI 理解论文

溯源树

样例

生成溯源树，研究论文发展脉络

Chat Paper

正在生成论文摘要